Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Enhancement of Cell-Based Vaccine Manufacturing through Process Intensification

William Whitford, Alain M. SourabiÈ and Dushyant B. Varshney
PDA Journal of Pharmaceutical Science and Technology March 2022, 76 (2) 151-162; DOI: https://doi.org/10.5731/pdajpst.2020.012583
William Whitford
1DPS Group, 959 Concord St #100, Framingham, MA 01701; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: William.whitford@dpsgroupglobal.com
Alain M. SourabiÈ
2Procelys by Lesaffre, 103 Rue Jean Jaurès, 94700 Maisons-Alfort, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dushyant B. Varshney
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Fenn E. A.
    1. Saunders P.
    Edward Jenner: The Cheltenham Years, 1795–1823: Being a Chronicle of the Vaccination Campaign; University Press of New England: Hanover, NH, 1982, Fenn E. A. Pox Americana: The Great Smallpox Epidemic of 1775–1782; Hill and Wang: New York, 2001.
  2. 2.↵
    1. Liddell J. M.
    Comparison of new vaccine approaches – COVID-19. Eur. Pharm. Rev. 2020, (3).
  3. 3.↵
    1. Plotkin S. A.,
    2. Orenstein W. A.,
    3. Offit P. A.,
    4. Edwards K. M.
    1. Gomez P. L.,
    2. Robinson J. M.
    Vaccine Manufacturing. In Plotkin's Vaccines, 7th ed.; Plotkin S. A., Orenstein W. A., Offit P. A., Edwards K. M., Eds.; Elsevier, 2018; 51–60.e1.
  4. 4.↵
    1. Negrete A.,
    2. Kotin R. M.
    Strategies for Manufacturing Recombinant Adeno-Associated Virus Vectors for Gene Therapy Applications Exploiting Baculovirus Technology. Briefings Funct. Genomics 2008, 7, (4), 303–311.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Aslanidi G.,
    2. Krotova K.
    Development of AAV6-Based Vaccine with Prime-Boost Capacity by Using Exosome-Protected Viral Particles. J. Immunol. 2020, 204 (1 Suppl.), 24.91.
    OpenUrl
  6. 6.↵
    1. Huang X.,
    2. Wang X.,
    3. Zhang J.,
    4. Xia N.,
    5. Zhao Q.
    Escherichia coli-Derived Virus-like Particles in Vaccine Development. NPJ Vaccines 2017, 2 (1), 3.
    OpenUrl
  7. 7.↵
    1. Whitford W.,
    2. Nelson D.
    From Interest in Intensification to a Factory of the Future. BioProcess Int. 2019, 17 (6), 24–30.
    OpenUrl
  8. 8.↵
    Intensifying Vaccine Production. https://www.who.int/bulletin/volumes/98/5/20-020520.pdf (accessed January 27, 2022).
  9. 9.↵
    1. Plotkin S.,
    2. Robinson J. M.,
    3. Cunningham G.,
    4. Iqbal R.,
    5. Larsen S.
    The Complexity and Cost of Vaccine Manufacturing – an Overview. Vaccine 2017, 35 (33), 4064–4071.
    OpenUrlPubMed
  10. 10.↵
    1. Mandal A.
    What Are Vaccines? https://www.newsmedical.net/health/What-are-Vaccines.aspx (accessed January 27, 2022).
  11. 11.↵
    1. Simmons N. L.
    Cultured Monolayers of MDCK Cells: A Novel Model System for the Study of Epithelial Development and Function. Gen. Pharmacol. 1982, 13 (4), 287–291.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Frenzel A.,
    2. Schirrmann T.,
    3. Hust M.
    Phage Display-Derived Human Antibodies in Clinical Development and Therapy. MAbs 2016, 8 (7), 1177–1194.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Tripathi N. K.,
    2. Shrivastava A.
    Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development. Front. Bioeng. Biotechnol. 2019, 7, 420.
    OpenUrl
  14. 14.↵
    1. Whitford W
    . Process Intensification in Animal Cell-based Vaccine Manufacture. https://ispe.org/pharmaceutical-engineering/ispeak/process-intensification-animal-cell-based-vaccine-manufacture (accessed January 27, 2022).
  15. 15.↵
    1. Godawat R.,
    2. Konstantinov K.,
    3. Rohani M.,
    4. Warikoo V.
    End-to-End Integrated Fully Continuous Production of Recombinant Monoclonal Antibodies. J. Biotechnol. 2015, 213, 13–19.
    OpenUrl
  16. 16.↵
    1. Laroche C.,
    2. Sanraman M. A.,
    3. Du G.,
    4. Pandey A.
    1. Portner R.,
    2. Barradas O.P.,
    3. Frahm B.,
    4. Hass V. C
    , Advanced Process and Control Strategies for Bioreactors. In: Current Developments in Biotechnology and Bioengineering: Bioprocesses, Biorectors and Controls; Laroche C., Sanraman M. A., Du G., Pandey A., Eds.; Elsevier B.V: Amsterdam, The Netherlands, 2017; 463–493.
  17. 17.↵
    1. Manzano T.,
    2. Langer G.
    Getting Ready for Pharma 4.0: Data Integrity in Cloud and Big Data Applications. Pharmaceutical Engineering 2018, 72–79.
  18. 18.↵
    1. Afrin F.,
    2. Hemey H.,
    3. Ozbak H.
    1. María R. R.,
    2. Arturo C. J.,
    3. Alicia J. A.,
    4. Paulina M. G.,
    5. Gerardo A. O.
    The Impact of Bioinformatics on Vaccine Design and Development. In Vaccines; Afrin F., Hemey H., Ozbak H., Eds.; InTech: Rjeka, Croatia, 2017.
  19. 19.↵
    1. Adams B.
    Moderna Wins Bragging Rights as It Kick-Starts First Experimental Coronavirus Clinical Trial, 2020. Fierce Biotech Web site. https://www.fiercebiotech.com/biotech/moderna-wins-bragging-rights-as-it-kickstarts-first-experimental-coronavirus-clinical-trial (accessed January 27, 2022).
  20. 20.↵
    1. Laroche C.,
    2. Sanraman M. A.,
    3. Du G.,
    4. Pandey A.
    Current Developments in Biotechnology and Bioengineering: Bioprocesses, Biorectors and Controls; Laroche C., Sanraman M. A., Du G., Pandey A., Eds.; Elsevier B.V: Amsterdam, The Netherlands, 2016.
  21. 21.↵
    Smart Manufacturing with Artificial Intelligence: A Digital Twin Strategy for Accelerated Innovation and Industrial Scale-up. https://xtalks.com/webinars/smart-manufacturing-with-artificial-intelligence-a-digital-twin-strategy-for-accelerated-innovation-and-industrial-scale-up/ (accessed January 27, 2022).
  22. 22.↵
    1. Narayanan H.,
    2. Luna M. F.,
    3. von Stosch M.,
    4. Cruz Bournazou M. N.,
    5. Polotti G.,
    6. Morbidelli M.,
    7. Butté A.,
    8. Sokolov M.
    Bioprocessing in the Digital Age: The Role of Process Models. Biotechnol. J. 2020, 15 (1), 1900172.
    OpenUrlCrossRef
  23. 23.↵
    1. Grumezescu A. M.,
    2. Holban A. M.
    1. Mohammadi V.,
    2. Minaei S.
    Artificial Intelligence in the Production Process. In Engineering Tools in the Beverage Industry; Grumezescu A. M., Holban A. M., Eds.; Woodhead Publishing: Cambridge, England, 2019; 27–63.
  24. 24.↵
    1. Wang B.,
    2. Wang Z.,
    3. Chen T.,
    4. Zhao X.
    Development of Novel Bioreactor Control Systems Based on Smart Sensors and Actuators. Front. Bioeng. Biotechnol. 2020, 8, 7.
    OpenUrl
  25. 25.↵
    AI in Operations Team. Xavier Health Web site. https://www.xavierhealth.org/aio-team (accessed January 27, 2022).
  26. 26.↵
    MAST Platform: System for Transferring Samples from Bioreactors to Analytical Devices. http://mastsampling.com/mast-platform/ (accessed January 27, 2022)
  27. 27.↵
    Berkeley Lights. https://www.berkeleylights.com (accessed January 27, 2022)
  28. 28.↵
    Scale-Up Right First Time With AllegroTM STR Bioreactors. https://go.pall.com/STR-PPC.html?utm_source=google&utm_medium=cpc&utm_campaign=18-02-121-STRBZ&utm_content=text_ad&utm_term=bioreactor&gclid=Cj0KCQiAosmPBhCPARIsAHOen-NAtU7OzIkucZ5aEc1PEgJC7XWWEbmaRfQo9rZEZZoDKpSBaVneOP4aAiq-EALw_wcB (accessed January 27, 2022).
  29. 29.↵
    DPS Group and TRIA Congratulate Moderna on ISPE 2019 Facility of the Future Category Award. https://www.dpsgroupglobal.com/news/2019/4/dps-group-and-tria-congratulate-moderna-on–ispe-2019-facility-of-the-future-category-award/ (accessed January 27, 2022).
  30. 30.↵
    Univercells NevoLine™ Biomanufacturing Platform. https://www.univercellstech.com/nevoline-biomanufacturing-platform/ (accessed January 27, 2022).
  31. 31.↵
    2020 FOYA Category Winner for Facility of the Future & Overall Winner. https://ispe.org/facility-yearawards/winners/2020/facility-future (accessed January 27, 2022).
  32. 32.↵
    ProCel. Procelys Web site. https://procelys.com/our-ranges/procel/ (accessed January 27, 2022).
  33. 33.↵
    1. Jagschies G.,
    2. Lindskog E.,
    3. Lacki K.,
    4. Galliher P.
    1. Whitford W. G.,
    2. Lundgren M.,
    3. Fairbank A.
    Cell Culture Media in Bioprocessing. In Biopharmaceutical Processing; Jagschies G., Lindskog E., Lacki K., Galliher P., Eds.; Elsevier: Amsterdam, The Netherlands, 2018; 147–162.
  34. 34.↵
    Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems. Mammalian and Insect Cell Systems. Pharma’s Almanac Web site. https://www.pharmasalmanac.com/articles/production-of-aav-vectors-using-suspension-mammalian-and-insect-cell-systems (accessed January 27, 2022).
  35. 35.↵
    1. Cao W.,
    2. Cao H.,
    3. Yi X.,
    4. Zhuang Y.
    Development of a Simple and High-Yielding Fed-Batch Process for the Production of Porcine Circovirus Type 2 Virus-like Particle Subunit Vaccine. AMB Expr. 2019, 9 (1), 164. https://link.springer.com/article/10.1186/s13568-019-0880-8.
    OpenUrl
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 76 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 76, Issue 2
March/April 2022
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Enhancement of Cell-Based Vaccine Manufacturing through Process Intensification
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Enhancement of Cell-Based Vaccine Manufacturing through Process Intensification
William Whitford, Alain M. SourabiÈ, Dushyant B. Varshney
PDA Journal of Pharmaceutical Science and Technology Mar 2022, 76 (2) 151-162; DOI: 10.5731/pdajpst.2020.012583

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Enhancement of Cell-Based Vaccine Manufacturing through Process Intensification
William Whitford, Alain M. SourabiÈ, Dushyant B. Varshney
PDA Journal of Pharmaceutical Science and Technology Mar 2022, 76 (2) 151-162; DOI: 10.5731/pdajpst.2020.012583
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • 1. Introduction
    • 2. Cell-Based Vaccine Production
    • 3. Animal Cells
    • 4. Bacteria
    • 5. Need for Vaccine Process Intensification
    • 6. Intensification Techniques
    • 7. Conclusion
    • Conflict of Interest Declaration
    • Footnotes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
Show more Commentary

Similar Articles

Keywords

  • Intensification
  • process
  • digital
  • optimization
  • production
  • Vaccine
  • Manufacturing
  • efficiency

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire